Tetrasine Interactions
There are 49 drugs known to interact with Tetrasine (tetrahydrozoline ophthalmic), along with 4 disease interactions. Of the total drug interactions, 6 are major, and 43 are moderate.
- View all 49 medications that may interact with Tetrasine
- View Tetrasine disease interactions (4)
Most frequently checked interactions
View interaction reports for Tetrasine (tetrahydrozoline ophthalmic) and the medicines listed below.
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Biotene Moisturizing Mouth Spray (saliva substitutes topical)
- bisacodyl
- buspirone
- Eliquis (apixaban)
- Gas-X (simethicone)
- Inbrija (levodopa)
- lidocaine
- Linzess (linaclotide)
- magnesium glycinate
- magnesium oxide
- Maxitrol (dexamethasone / neomycin / polymyxin b ophthalmic)
- Metoprolol Succinate ER (metoprolol)
- Motegrity (prucalopride)
- Mucinex Instasoothe Sore Throat + Cough Relief (dextromethorphan / hexylresorcinol)
- Neo-Poly-Dex (dexamethasone / neomycin / polymyxin b ophthalmic)
- Novocain (procaine)
- Nuplazid (pimavanserin)
- Omega-3 Fish Oil (omega-3 polyunsaturated fatty acids)
- Ongentys (opicapone)
- Paxil (paroxetine)
- Phazyme Maximum Strength (simethicone)
- Prolia (denosumab)
- prucalopride
- pyridostigmine
- Q-Sorb Co Q-10 (ubiquinone)
- Refresh (ocular lubricant ophthalmic)
- Rytary (carbidopa / levodopa)
- selegiline
- Senna S (docusate/senna)
Tetrasine disease interactions
There are 4 disease interactions with Tetrasine (tetrahydrozoline ophthalmic) which include:
Report options
QR code containing a link to this page
More about Tetrasine (tetrahydrozoline ophthalmic)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic antihistamines and decongestants
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.